Acid–base reaction-based dispersive solid phase extraction of favipiravir using biotin from biological samples prior to capillary electrophoresis analysis-Reference-Cited by-同舟云学术

Acid–base reaction-based dispersive solid phase extraction of favipiravir using biotin from biological samples prior to capillary electrophoresis analysis

Published:2024 Issue:27 Volume:14 Page:19612-19618
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Safari Elnaz¹,Seyfinejad Behrouz²³^ORCID,Farajzadeh Mir Ali⁴⁵^ORCID,Afshar Mogaddam Mohammad Reza³^ORCID,Nemati Mahboob¹³^ORCID

Affiliation:

1. Pharmaceutical and Food Control Department, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

2. Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3. Food and Drug Safety Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

4. Department of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran

5. Engineering Faculty, Near East University, 99138 Nicosia, Mersin 10, North Cyprus, Turkey

Abstract

An acid–base reaction-based dispersive solid-phase extraction method was developed for the extraction of favipiravir from deionized water, plasma and urine samples prior to its determination using a capillary electrophoresis-diode array detector.

Funder

Tabriz University of Medical Sciences

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D3RA07356D

Reference27 articles.

1. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

2. Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19

3. Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference

4. Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma

5. Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DETERMINATION OF ANTIVIRAL-DRUG FAVIPIRAVIR FROM BIOLOGICAL SAMPLES BY USING MOLECULAR IMPRINTED POLYMER-BASED ELECTROCHEMICAL SENSOR;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-08-14